Monday, January 13, 2020 10:26:36 PM
I prefer weekly charts. You could make a case the daily chart has some H & S characteristics. but I don't think so.
as you know I've monitored the weekly moving average as a buy/add point. The weekly moving avg. is $5.46 right now.
I have some cash and am looking to get back in. Debating buying at $5.50 but would prefer to get in at $5 - $4.75 area. We may never see that though.
I'd be very comfortable buying this business at a $200 million market cap (about $5 a share) or lower.
No position trying to be patient.
Sold VNTR at loss and QUAD at profit. My tax loss plays. Not much action this year.
Long TAYD, PEYE and ATGN. Monitoring FSI
as you know I've monitored the weekly moving average as a buy/add point. The weekly moving avg. is $5.46 right now.
I have some cash and am looking to get back in. Debating buying at $5.50 but would prefer to get in at $5 - $4.75 area. We may never see that though.
I'd be very comfortable buying this business at a $200 million market cap (about $5 a share) or lower.
No position trying to be patient.
Sold VNTR at loss and QUAD at profit. My tax loss plays. Not much action this year.
Long TAYD, PEYE and ATGN. Monitoring FSI
Recent KRMD News
- KORU Medical Systems to Report First Quarter 2026 Financial Results on May 6, 2026 • Business Wire • 04/16/2026 12:00:00 PM
- KORU Medical Systems Announces EU MDR Certification for the Freedom60® Infusion Pump With Prefilled Syringe Compatibility • Business Wire • 03/13/2026 12:00:00 PM
- KORU Medical Systems Announces CEO Transition • Business Wire • 03/12/2026 08:08:00 PM
- KORU Medical Systems Announces +20% Fourth Quarter and Full Year 2025 Revenue Growth, Positive Adjusted EBITDA and Initiates Full Year 2026 Guidance • Business Wire • 03/12/2026 08:05:00 PM
- KORU Medical Systems to Report Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026 • Business Wire • 02/26/2026 09:05:00 PM
- KORU Medical Systems Receives FDA 510(k) Clearance for Delivery of RYSTIGGO® (rozanolixizumab-noli), Expanding Label for FreedomEDGE® Infusion System • Business Wire • 01/29/2026 09:05:00 PM
- KORU Medical Systems Reports Preliminary Q4 and Full Year 2025 Results; Achieves Record Revenue and Full Year Positive Operating Cash Flow • Business Wire • 01/12/2026 01:00:00 PM
- KORU Medical Systems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 01/05/2026 12:00:00 PM
- KORU Medical Systems Announces 510(k) Submission for Clearance of the FreedomEDGE® System with a Commercialized Oncology Biologic • Business Wire • 12/30/2025 09:05:00 PM
- KORU Medical Systems, Inc. Appoints Eric Schiller as Chief Technology Officer • Business Wire • 12/16/2025 09:05:00 PM
- KORU Medical Systems to Present Promising Results on the Use of the FreedomEDGE® Syringe Infusion System in Infusion Centers at ESID/EHA/SIOPE Focused Symposium 2025 • Business Wire • 11/17/2025 09:05:00 PM
- KORU Medical Systems to Participate in Upcoming Investor Conferences • Business Wire • 11/13/2025 01:00:00 PM
- KORU Medical Systems Announces 27% Q3 Revenue Growth and Raises 2025 Revenue Guidance • Business Wire • 11/12/2025 09:05:00 PM
- KORU Medical Systems Announces Development Agreement for Innovation in Subcutaneous Immunoglobulin Infusion Systems • Business Wire • 11/04/2025 09:05:00 PM
- KORU Medical Systems to Report Third Quarter 2025 Financial Results on November 12, 2025 • Business Wire • 10/22/2025 08:05:00 PM
- ForCast Orthopedics and KORU Medical Systems Announce Agreement for Novel Antibiotic Infusion Therapy • Business Wire • 09/18/2025 12:00:00 PM
- Cirtec Medical Announces Appointment of New Chief Executive Officer • GlobeNewswire Inc. • 08/28/2025 04:59:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/11/2025 08:26:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/11/2025 08:24:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/11/2025 08:23:25 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/11/2025 03:18:13 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/06/2025 08:11:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2025 08:08:43 PM
- KORU Medical Systems Announces Q2 2025 Financial Results, Including Record Double-digit Revenue, and Raises 2025 Revenue Guidance • Business Wire • 08/06/2025 08:05:00 PM
- KORU Medical Systems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 08/01/2025 08:55:00 PM
